Compare
Legence Corp. vs Sunrun Inc. vs Ameresco, Inc. vs Argan Inc
| Latest fiscal year | Legence Corp. LGN | Sunrun Inc. RUN | Ameresco, Inc. AMRCLast annual report: year ended 2024-12-31 | Argan Inc AGX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2024-12-31 | 2026-01-31 |
| Revenue | $2.55B | $2.96B | $1.77B | $944.61M |
| Revenue growth (YoY) | +21.5% | +45.1% | +28.8% | +8.1% |
| Gross margin | 21.0% | n/a | 14.5% | 20.5% |
| Operating margin | 2.4% | -4.3% | 6.1% | 14.3% |
| Net margin | -2.3% | 15.2% | 3.0% | 14.6% |
| Net income | -$59.78M | $449.95M | $53.94M | $137.77M |
| EPS (Diluted) | n/a | $1.71 | $1.07 | $9.74 |
| Operating cash flow | $256.87M | -$421.44M | $117.60M | $414.72M |
| Free cash flow | $218.93M | n/a | $113.31M | $410.84M |
| Cash & equivalents | $230.17M | n/a | $108.52M | $339.48M |
| Total assets | $2.68B | $22.61B | $4.16B | $1.19B |
| Total liabilities | $1.89B | $17.63B | n/a | $724.09M |
| Shareholders' equity | $392.20M | $4.27B | $1.05B | $462.26M |
| Return on year-end equity | -15.2% | 10.5% | 5.2% | 29.8% |
| Shares outstanding | n/a | 233.61M | n/a | 13.95M |
Revenue, most recent five fiscal years
| Fiscal year | Legence Corp. | Sunrun Inc. | Ameresco, Inc. | Argan Inc |
|---|---|---|---|---|
| Latest | $2.55B Ended 2025-12-31 | $2.96B Ended 2025-12-31 | $1.77B Ended 2024-12-31 | $944.61M Ended 2026-01-31 |
| 1 year earlier | $2.10B Ended 2024-12-31 | $2.04B Ended 2024-12-31 | $1.37B Ended 2023-12-31 | $874.18M Ended 2025-01-31 |
| 2 years earlier | $1.62B Ended 2023-12-31 | $2.26B Ended 2023-12-31 | $1.82B Ended 2022-12-31 | $573.33M Ended 2024-01-31 |
| 3 years earlier | n/a | $2.32B Ended 2022-12-31 | $1.22B Ended 2021-12-31 | $455.04M Ended 2023-01-31 |
| 4 years earlier | n/a | $1.61B Ended 2021-12-31 | $1.03B Ended 2020-12-31 | $509.37M Ended 2022-01-31 |